The immune response to a polyoma virus replicon-based DNA vaccine

Vaccine

Volumn 19, Issue 1, 2000, Pages 68-74

  Mena, A ^a   Coupar, B E H ^b   Andrew, M E ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b CSIRO   (Australia)

Author keywords

Antibody; DNA vaccine; Polyoma replicon

Indexed keywords

ANTIBODY; DNA VACCINE; HEMAGGLUTININ;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; DNA REPLICATION; DNA TRANSFECTION; DRUG EFFICACY; FEMALE; GENE GUN; GENE NUMBER; HEMAGGLUTINATION INHIBITION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VIRUS; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; REPLICON; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CELLS, CULTURED; DNA, VIRAL; FEMALE; GENES, REPORTER; IMMUNITY; LUCIFERASES; MICE; MICE, INBRED CBA; POLYOMAVIRUS; REPLICON; TRANSFECTION; VACCINES, DNA;

EID: 0034663543     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00147-X     Document Type: Article

References (28)

1. Wolff J.A., Malone R.W., William P., et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
2. Acsadi G., Dickson G., Love D.R., et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 352:1991;815-818.
3. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Human Gene Therapy. 4:1993;151-159.
4. Manthorpe M., Jensen F.C., Hartikka J., et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Human Gene Therapy. 4:1993;419-431.
5. Levy M.N., Barron L.G., Meyer K.B., Szoka F.C. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products in blood. Gene Therapy. 3:1995;201-211.
6. Eisenbraun M.D., Fuller D.H., Haynes J.R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA and Cell Biology. 2:1993;791-797.
7. Danko I., Fritz J.D., Jiao S., Hogan K., Latendresse J.S., Wolff J.A. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Therapy. 1:1994;114-121.
8. Li L., Hoffman R.M. The feasibility of targeted selective gene therapy of the hair follicle. Nature Medicine. 1:1995;705-706.
9. Winegar R.A., Monforte J.A., Suing K.D., O'Loughlin K.G., Rudd C.J., Macgregor J.T. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridisation. Human Gene Therapy. 7:1996;2185-2194.
10. O'Hare K. Replication of polyoma plasmid recombinants in mouse cells. J. Molec. Biol. 151:1981;203-210.
11. Mungal S., Steinberg B.M., Taichman L.B. Replication of plasmid-derived human papillomavirus type 11 DNA in cultured keratinocytes. J. Virol. 66:1992;3220-3224.
12. Iguchi-Ariga S.M.M., Ogawa N., Ariga H. Identification of the initiation in the murine immunoglobulin heavy chain gene and possible function of the octamer motif as a putative DNA replication origin in mammalian cells. Biochim. Biophys. Acta. 1172:1993;73-81.
13. Gassmann M., Donoho G., Berg P. Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA. 92:1995;1292-1296.
14. Camenisch G., Gruber M., Donoho G., Sloun P.V., Wenger R.H., Gassmann M. A polyoma-based episomal vector efficiently expresses exogenous genes in mouse embryonic stem cells. Nucl. Acid Res. 24:1996;3707-3713.
15. Mucke S, Polack A, Pawlita M et al. Suitability of Epstein-Barr virus based episomal vectors for expression of cytokine genes in human lymphoma cells. 1997;4:82-92.
16. Fried M., Prives C. The biology of simian virus 40 and polyomavirus. Cancer Cells. 4:1986;1-16.
17. Weinberg D.H., Collins K.L., Simancek P., et al. Reconstitution of simian virus 40 DNA replication with purified proteins. Proc. Natl. Acad. Sci. USA. 87:1990;8692-8696.
18. Treisman R., Novak U., Favaloro J., Kaman R. Transformantion of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature. 292:1981;595-600.
19. Bouchard L., Gelinas C., Asselin C., Bastin M. Tumorigenic activity of polyoma virus and SV40 DNAs in newborn rodents. Virology. 135:1984;53-64.
20. Berger H., Wintersberger E. Polyomavirus small T antigen enhances replication of viral genomes in 3T6 mouse fibroblasts. J. Virol. 60:1986;768-770.
21. Sato Y., Roman M., Tighe H., et al. Immunostimuatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1986;352-354.
22. Yi A., Tuetken R., Redford T., Waldschmidt M., Kirsch J., Krieg A.M. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol. 160:1998;4755-4761.
23. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Molec. Biol. 26:1967;365-369.
24. Cahill K.B., Roome A.J., Carmichael G.G. Replication-dependent transactivation of the polyomavirus late promoter. J. Virol. 64:1990;992-1001.
25. Lacks S., Greenberg B. Complementary specificity of restriction endonucleases of Diplococcus pnemoniae with respect to DNA methylation. J. Molec. Biol. 114:1977;153-168.
26. Torres A.T., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
27. Pertmer T.M., Eisenbraun M.D., McCade D., Prayaga S.K., Fuller D.H., Haynes J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
28. Kucerova L. DNA/genetic vaccination. Viral Immunol. 11:1998;55-63.